Intrinsic Value of S&P & Nasdaq Contact Us

DICE Therapeutics, Inc. DICE NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
43/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$60.00
+26.2%

Stock Statistics — DICE

DICE Therapeutics, Inc. (DICE) has a market capitalization of $2.27B and trades at $47.55. The 52-week range is 15.08-47.9.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -23, Earnings Per Share (EPS) of $-2.07.

The stock has a beta of 0.00, operates in the Healthcare sector.

Trading Data
Current Price$47.55
52-Week Range15.08-47.9
Volume4.33M
Avg Volume (30D)1.75M
Market Cap$2.27B
Beta (1Y)0.00
Company
IPO Date2021-09-15
Employees71
CEOJ. Kevin Judice
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS23345J1043
CUSIP23345J104
Income (Latest Year)
EBITDA$-83.01M
Operating Income$-88.22M
Net Income$-81.66M
EPS$-2.07
EPS Diluted$-2.07
Shares Outstanding$39.4M
Balance Sheet (Latest Year)
Total Assets$593.98M
Current Assets$577.76M
Cash & ST Investments$574.23M
Total Liabilities$26.99M
Total Debt$13.27M
Net Debt$-448.13M
Total Equity$-187.59M
Debt / Equity-0.07
Valuation Ratios
P/E Ratio-23
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message